Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism IGF2BP1 modulators(insulin like growth factor 2 mRNA binding protein 1 modulators), MBL modulators(Mannose-binding protein C modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lysosomal Storage Diseases | Preclinical | - | 28 Dec 2022 |